Nicole Murphy

All filings by Nicole Murphy on record concern Biogen Inc., in the capacity of senior executive. Between 12 February 2022 and 12 February 2026, the trades on record add up to 45 filings.

No open-market sale appears; the market trades are 1 purchase worth €493. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 23 share grants and 21 option exercises. So far in 2026, the count stands at 1 purchase and no sales.

The newest entry dates from 17 February 2026: an open-market purchase of €493, in Biogen Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.